HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gm(m)

serum factor associated with Fc fraction of IgG heavy chain
Also Known As:
GMM
Networked: 50 relevant articles (3 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Attar, Eyal C: 1 article (03/2013)
2. Powell, Bayard L: 1 article (03/2013)
3. Kolitz, Jonathan E: 1 article (03/2013)
4. Moser, Barry: 1 article (03/2013)
5. Bloomfield, Clara D: 1 article (03/2013)
6. Voorhees, Peter: 1 article (03/2013)
7. DeAngelo, Daniel J: 1 article (03/2013)
8. Amrein, Philip C: 1 article (03/2013)
9. Wadleigh, Martha: 1 article (03/2013)
10. Johnson, Jeffrey L: 1 article (03/2013)

Related Diseases

1. Stroke (Strokes)
04/01/1981 - "NP infusion (average 33 micron/min) proved beneficial in each: LVSP 192 mm Hg was reduced to 164; arterial SP decrement equaled LVSP change; LV end-diastolic pressure 19 mm Hg declined to 10: cardiac index (2.73 L/min/m2) and heart rate were unaltered; total systemic vascular resistance 1433 dsc-5 decreased to 1201; elevated LV stroke work index 92 gm.m/m2 was diminished to 74. "
06/01/1987 - "In the CEPA cohort, cardiac index fell from 3.50 to 2.85 L/min-m2 after supplemental GA administration, fell to a low of 2.30 L/min-m2 and remained at that range throughout the study; left ventricular stroke work index fell from 50 to 35 gm-m/m2 and remained depressed throughout. "
01/01/2012 - "The mean right atrial pressure (pre-ECP: 9 ± 4 mmHg; 20-min-ECP: 12 ± 5 mmHg; 40-min-ECP: 12 ± 4 mmHg; and post-ECP: 9 ± 4 mmHg), pulmonary wedge pressure (16 ± 6 mmHg, 20 ± 7 mmHg, 20 ± 7 mmHg, and 17 ± 7 mmHg, respectively), cardiac index (2.4 ± 0.4 l/min/m(2), 2.8 ± 0.6 l/min/m(2), 2.7 ± 0.5 l/min/m(2), and 2.5 ± 0.4 l/min/m(2), respectively), cardiac work index (2.5 ± 0.4 kgm/m(2), 3.3 ± 0.8 kgm/m(2), 3.1 ± 0.8 kgm/m(2), and 2.6 ± 0.5 kgm/m(2), respectively), and left ventricular stroke work index (32 ± 7 gm/m(2), 41 ± 12 gm/m(2), 39 ± 12 gm/m(2), and 33 ± 8 gm/m(2), respectively) significantly (p<0.05) increased after ECP was commenced (pre-ECP vs. 20-min-ECP) and decreased after ECP was discontinued (40-min-ECP vs. post-ECP). "
01/01/2010 - "His right ventricular stroke work index was lowered from 19 to seven g-m/m2/beat; his pulmonary vascular resistance index from 267 to 190 dynes•seconds/cm5/m2; left ventricular stroke work index from 28 to 16 gm-m/m2/beat; and his pulmonary arterial wedge pressure was lowered from 32 to 24 mmHg with a lower mean airway pressure compared to conventional ventilation. "
06/01/2001 - "However, these changes were greater in the VD + IS group, in which LDM stimulation increased peak aortic pressure by 17.6 +/- 1.7 mm Hg, peak LV pressure by 19.7 +/- 1.1 mm Hg, peak positive LV dp/dt by 398 +/- 144 mm Hg per second, stroke volume by 5.1 +/- 0.7 mL, stroke work by 10.9 +/- 0.9 gm.m, and stroke power by 122.7 +/- 11.6 gm.m per second (p < 0.05 compared with VD + CS). "
2. Myelodysplastic Syndromes (Myelodysplastic Syndrome)
3. Lupus Nephritis
4. Neoplasms (Cancer)
5. Mucositis

Related Drugs and Biologics

1. Cytarabine (Cytosar-U)
2. Enoximone
3. Daunorubicin (Cerubidine)
4. bortezomib (Velcade)
5. bipiperidyl mustard (BPM)
6. Cyclosporine (Ciclosporin)
7. Prednisone (Sone)
8. Cyclophosphamide (Cytoxan)
9. mycophenolate mofetil (Cellcept)
10. Oxygen

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Nutritional Support (Artificial Feeding)
3. Salvage Therapy
4. Counterpulsation (External Counterpulsation)
5. Radiotherapy